NanOlogy

0 followers


NanOlogy™ is a clinical-stage oncology company formed in 2015 to develop a patented submicron particle technology to deliver high, sustained concentration of chemoimmunology agents directly to the site of disease.

Employees

1-10

Links


Org chart

H. Paul Dorman
Chairman & CEO
Collapse
Mark Mitchell
Legal, Regulatory, General Management
Maxwell Lea
Finance, Corporate Development, General Management
Marc Iacobucci
Product Development, Business Development, General Management

Board & advisors


Teams

This company has no teams yet